Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Akribion Genomics Logo
Akribion Genomics Growth Score
72
CB Rank
71747
Heat Score
53
Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.
PrivateSeed Zwingenberg, Hessen, Germany11-50 www.akribion-genomics.com/
Biotechnology
Health Care
Oncology
Overview

Akribion Genomics
Total Funding
obfuscation
Growth Score
72
Heat Score
53

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score72
-5 pts
in past quarter
Heat Score 53
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Akribion Genomics

CB Rank
71747
Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.
PrivateSeed Zwingenberg, Hessen, Germany11-50 www.akribion-genomics.com/
Biotechnology
Health Care
Oncology

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Also Known As Akribion Therapeutics
Operating Status Active
Company Type For Profit
Founders  Lukas Linnig, Michael Krohn
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

CRISPR Nuclease Technology
A gene-editing tool used to modify genetic material for developing cancer therapies and other treatments.
Cancer Therapy Development
Development of novel cancer treatments using genome editing and targeted cell depletion techniques.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed
obfuscation
Seed Round - Akribion Genomics Logo
Seed Round - Akribion Genomics
6
obfuscation
Carma Fund, RV InvestSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News

News and Press

News•Feb 4, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

207

IT Spend

$202.9KThis year, Akribion Genomics is projected to spend $202.9K on IT, according to Aberdeen.

Active Website Tech Count

3Akribion Genomics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Person Schema.
Sub-Organizations
Frequently Asked Questions

Where is Akribion Genomics's headquarters? Akribion Genomics is located in Zwingenberg, Hessen, Germany.Who invested in Akribion Genomics? Akribion Genomics has 6 investors including RV Invest and  HTGF (High-Tech Gruenderfonds).When was the last funding round for Akribion Genomics? Akribion Genomics closed its last funding round on
obfuscation
from a Seed round.Who are Akribion Genomics's competitors? Alternatives and possible competitors to Akribion Genomics may include Verve Therapeutics, Prime Medicine, and  Synthego.How much funding has Akribion Genomics raised to date? Akribion Genomics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|